Riskpilot← Back to searchSign inGet full accessDan Sevonius AB
ABActiveOrg 5569682809Medical specialists activities · NACE 8622Est. 20140 employees
Revenue 2024
SEK 3M
+4% vs 2023
EBITDA margin
48.4%
+27% vs 2023
Equity ratio
90.2%
Financial strength
Net profit 2024
SEK 2,1M
+134% vs 2023
| Revenue | SEK 3M | +4% |
| EBITDA | SEK 1,5M | +27% |
| Net profit | SEK 2,1M | +134% |
| Total assets | SEK 7,8M | +6% |
| Equity | SEK 7,1M | +27% |
| Employees | 0 | — |
Legal name
Dan Sevonius AB
Org number
5569682809
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
10 april 2014
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av Sevonius, Dan Stefan
Company purpose
Aktiebolaget ska bedriva specialistläkarverksamhet, föreläsningar, video-produktioner samt handel med värdepapper.
Address
Phone
+46703590321
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 569 | 2 654 | 2 797 | 2 896 | 3 018 |
| Staff expenses | — | — | −1 303 | −1 429 | −1 438 |
| EBITDA | 2 128 | 1 234 | 1 268 | 1 147 | 1 460 |
| Depreciation & amort. | −46 | −111 | −111 | −111 | −102 |
| EBIT | 2 082 | 1 123 | 1 157 | 1 036 | 1 358 |
| Net financials | 14 | 15 | 20 | 82 | 101 |
| Profit before tax | 1 597 | 1 139 | 1 177 | 1 119 | 2 624 |
| Tax | −345 | −239 | −245 | −238 | −564 |
| Net profit | 1 252 | 900 | 932 | 880 | 2 061 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 6 173 | 6 529 | 7 025 | 7 393 | 7 849 |
| Equity | 4 263 | 4 743 | 5 215 | 5 575 | 7 076 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 745 | 621 | 646 | 653 | 773 |
| Total debt | 745 | 621 | 646 | 653 | 773 |
EBITDA margin
48.4%
This company
15.8%
Market median
+206% vs market
20202024
Equity ratio
90.2%
This company
38.2%
Market median
+136% vs market
20202024
Return on equity
29.1%
This company
18.4%
Market median
+58% vs market
20202024
Net profit margin
68.3%
This company
8.1%
Market median
+743% vs market
20202024
Asset turnover
0.38×
This company
1.12×
Market median
-66% vs market
20202024
Debt / equity
0.11×
This company
0.62×
Market median
+82% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Chairman | 2022 | |
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Dan Sevonius AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Dan Stefan Sevonius | Chairman | 0 companies |
| Emma Karin Liljeros | Deputy Board Member | 0 companies |
| Lena Dagny Catharina Sevonius | Board of Directors | 0 companies |
| Johanna Nora Sevonius Södergren | Deputy Board Member | 0 companies |